2018 annual financial data

Alnylam Pharmaceuticals 2018 Net margin

Direct answer

Net margin was -1,016.58%.

Operating income was -814.67M USD and net income was -761.5M USD.
Operating cash flow was -562.62M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
74.91M USD
Operating income
-814.67M USD
Net income
-761.5M USD
Operating cash flow
-562.62M USD